Treatment group | Systolic blood pressure | Diastolic blood pressure | |||
---|---|---|---|---|---|
R20 | Final evaluation point | R20 | Final evaluation point | ||
Placebo | No. of patients | 35 | 35 | 35 | 35 |
Mean ± SD | 123.8 ± 17.0 | 127.5 ± 20.3 | 72.7 ± 10.9 | 75.3 ± 9.9 | |
120 μg | No. of patients | 36 | 35 | 36 | 35 |
Mean ± SD | 128.3 ± 13.0 | 127.8 ± 13.5 | 73.6 ± 10.7 | 75.4 ± 10.5 | |
240 μg | No. of patients | 41 | 40 | 41 | 40 |
Mean ± SD | 128.3 ± 16.4 | 129.4 ± 13.7 | 74.4 ± 10.6 | 75.1 ± 8.9 |